{"member_organisations": "Accord Healtcare \nAmring Pharma \nBluefish Pharma \nCampus Pharma \nEQLPharma \nEvolan Pharma AB \nGlenmark \nKrka \nMedac \nMedartuum Medical AB \nMylan \nMylan Hospital \nOrifarm Generics \nPensa Pharma AB \nSandoz \nStada Nordic ApS \nSun/Alkaloida \nTeva", "identification_number": "153065529304-05", "fields_of_interest": "Public Health", "head_office_address": "J\u00f6rgen Folkersv\u00e4g 13", "full_time_equivalent_fte": "1", "person_with_legal_responsibility": "Kenneth Nyblom", "industry_forums": "", "grants": "", "country_code": "se", "inter_groups": "", "eu_initiatives": "L\u00e4kemedel, pharmaceuticals, generics, biosimilarer, biosimilars, apotek, substitution, utbytbarhet, generisk subsitution", "level_of_interest": "national", "organisation_name": "F\u00f6reningen f\u00f6r Generiska L\u00e4kemedel och Biosimilarer (FGL)", "belgium_office_post_code": "", "number_of_persons_involved": "1", "person_in_charge_of_eu_relations": "Kenneth Nyblom", "section": "II - In-house lobbyists and trade/business/professional associations", "lon": "17.1440283", "source": "", "subsection": "Trade and business associations", "belgium_office_phone": "", "overall_budget_turnover_as_a_range": "", "belgium_office_address": "", "persons_accredited_for_access_to_european_parliament_premises": "", "registration_date": "14/12/2017", "estimate_of_costs_absolute_amount": "", "website_address": "http://www.generikaforeningen.se", "commission_expert_groups_and_other_similar_entities_european_commission": "NA", "head_office_post_box": "", "head_office_city": "G\u00e4vle", "membership": "Medicines for Europe", "head_office_post_code": "80643", "position": "CEO", "financial_year_start_date": "01/01/2016", "head_office_country": "Sweden", "number_of_ep_accredited_persons": "", "relevant_communication": "FGL; F\u00f6reningen f\u00f6r Generiska L\u00e4kemedel och Biosimilarer arbetar fr\u00e4mst nationellt (i Sverige). F\u00f6reningen \u00e4r medlem i Medicines for Europe, som \u00e4r den europeiska paraplyorganisationen. Medicines for Europe samordnar och initierar aktiviteter som r\u00f6r EU. D\u00e4rmed \u00e4r FGL indirekt involverad i angel\u00e4genheter som ber\u00f6r EU.", "financial_year_end_date": "01/12/2016", "lat": "60.7059944", "estimate_of_costs_as_a_range": "200000-299999", "overall_budget_turnover_absolute_amount": "0", "legal_status": "F\u00f6rening", "procurement": "", "customers": "", "belgium_office_post_box": "", "goals__remit": "F\u00f6reningen f\u00f6r Generiska l\u00e4kemedel och Biosimilarer f\u00f6rkortad FGL \u00e4r en branschorganisation som arbetar f\u00f6r att patienten skall f\u00e5 samma h\u00f6ga kvalitet och s\u00e4kerhet p\u00e5 sina l\u00e4kemedel till ett l\u00e4gre pris.", "belgium_office_city": "", "head_office_phone": "(+46)705845910"}